Logo-jpe
Submitted: 02 May 2021
Accepted: 07 Jun 2021
ePublished: 03 Aug 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2021;6(1): e10.
doi: 10.34172/jpe.2021.10
  Abstract View: 765
  PDF Download: 562

Epidemiology and Prevention

Inhibiting inflammasome; the possible mechanisms of action of azithromycin against COVID-19?

Ali Saeedi-Boroujeni 1 ORCID logo, Mohammad Bahadoram 2 ORCID logo, Bijan Keikhaei 2, Mohammad-Reza Mahmoudian-Sani 2* ORCID logo, Azadeh Khayyat 3, Mohammad Ali Esmaeilpour 4

1 Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Thalassemia and Hemoglobinopathy Research Center, Research Institute of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Independent Researcher 4246 Graveley St., Burnaby, BC, Canada
4 Advent Health Graduate Medical Education, Center for Collaborative Research, Orlando, FL, USA
*Corresponding Author: Correspondence to: Mohammad-Reza MahmoudianSani, Email: , Email: mohamadsani495@gmail.com

Abstract

Cytokine storm and destructive inflammation in the severe form of COVID-19 lead to acute respiratory distress syndrome (ARDS)/acute lung injury (ALI), and dysfunction of several different body organs in patients. SARS-CoV-2 contains all inflammasome-activating proteins belonging to SARS-CoV and MERS-CoV viruses. Macrolides are known to possess immunomodulatory properties. Given the desirable results of azithromycin treatment for patients with a severe case of COVID-19, based on studies, it could be concluded that the immunomodulatory properties of azithromycin to inhibit inflammasome can help the treatment of patients with this disease.

Citation: Saeedi-Boroujeni A, Bahadoram M, Keikhaei B, Mahmoudian-Sani MR, Khayyat A, Esmaeilpour MA. Inhibiting inflammasome; the possible mechanisms of action of azithromycin against COVID-19? J Prev Epidemiol. 2021;6(1):e10. doi: 10.34172/ jpe.2021.10.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 766

Your browser does not support the canvas element.


PDF Download: 562

Your browser does not support the canvas element.